Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 43 entries
Sorted by: Best Match Show Resources per page
Molecular allergy diagnostics using multiplex assays: methodological and practical considerations for use in research and clinical routine: Part 21 of the Series Molecular Allergology.

Allergo journal international

Jakob T, Forstenlechner P, Matricardi P, Kleine-Tebbe J.
PMID: 27069843
Allergo J Int. 2015;24:320-332. doi: 10.1007/s40629-015-0087-8. Epub 2015 Dec 17.

The availability of single allergens and their use in microarray technology enables the simultaneous determination of specific IgE (sIgE) to a multitude of different allergens (> 100) in a multiplex procedure requiring only minute amounts of serum. This allows...

Cite
Jakob T, Forstenlechner P, Matricardi P, et al. Molecular allergy diagnostics using multiplex assays: methodological and practical considerations for use in research and clinical routine: Part 21 of the Series Molecular Allergology. Allergo J Int. 2015;24:320-332doi: 10.1007/s40629-015-0087-8.
Jakob, T., Forstenlechner, P., Matricardi, P., & Kleine-Tebbe, J. (2015). Molecular allergy diagnostics using multiplex assays: methodological and practical considerations for use in research and clinical routine: Part 21 of the Series Molecular Allergology. Allergo journal international, 24320-332. https://doi.org/10.1007/s40629-015-0087-8
Jakob, Thilo, et al. "Molecular allergy diagnostics using multiplex assays: methodological and practical considerations for use in research and clinical routine: Part 21 of the Series Molecular Allergology." Allergo journal international vol. 24 (2015): 320-332. doi: https://doi.org/10.1007/s40629-015-0087-8
Jakob T, Forstenlechner P, Matricardi P, Kleine-Tebbe J. Molecular allergy diagnostics using multiplex assays: methodological and practical considerations for use in research and clinical routine: Part 21 of the Series Molecular Allergology. Allergo J Int. 2015;24:320-332. doi: 10.1007/s40629-015-0087-8. Epub 2015 Dec 17. PMID: 27069843; PMCID: PMC4792369.
Copy Download .nbib Format: NLM
Guidelines on the management of IgE-mediated food allergies: S2k-Guidelines of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Medical Association of Allergologists (AeDA), the German Professional Association of Pediatricians (BVKJ), the German Allergy and Asthma Association (DAAB), German Dermatological Society (DDG), the German Society for Nutrition (DGE), the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS), the G.

Allergo journal international

Worm M, Reese I, Ballmer-Weber B, Beyer K, Bischoff SC, Classen M, Fischer PJ, Fuchs T, Huttegger I, Jappe U, Klimek L, Koletzko B, Lange L, Lepp U, Mahler V, Niggemann B, Rabe U, Raithel M, Saloga J, Schäfer C, Schnadt S, Schreiber J, Szépfalusi Z, Treudler R, Wagenmann M, Watzl B, Werfel T, Zuberbier T, Kleine-Tebbe J.
PMID: 27069841
Allergo J Int. 2015;24:256-293. doi: 10.1007/s40629-015-0074-0. Epub 2015 Nov 07.

No abstract available.

Cite
Worm M, Reese I, Ballmer-Weber B, et al. Guidelines on the management of IgE-mediated food allergies: S2k-Guidelines of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Medical Association of Allergologists (AeDA), the German Professional Association of Pediatricians (BVKJ), the German Allergy and Asthma Association (DAAB), German Dermatological Society (DDG), the German Society for Nutrition (DGE), the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS), the G. Allergo J Int. 2015;24:256-293doi: 10.1007/s40629-015-0074-0.
Worm, M., Reese, I., Ballmer-Weber, B., Beyer, K., Bischoff, S. C., Classen, M., Fischer, P. J., Fuchs, T., Huttegger, I., Jappe, U., Klimek, L., Koletzko, B., Lange, L., Lepp, U., Mahler, V., Niggemann, B., Rabe, U., Raithel, M., Saloga, J., Schäfer, C., Schnadt, S., Schreiber, J., Szépfalusi, Z., Treudler, R., Wagenmann, M., Watzl, B., Werfel, T., Zuberbier, T., & Kleine-Tebbe, J. (2015). Guidelines on the management of IgE-mediated food allergies: S2k-Guidelines of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Medical Association of Allergologists (AeDA), the German Professional Association of Pediatricians (BVKJ), the German Allergy and Asthma Association (DAAB), German Dermatological Society (DDG), the German Society for Nutrition (DGE), the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS), the G. Allergo journal international, 24256-293. https://doi.org/10.1007/s40629-015-0074-0
Worm, Margitta, et al. "Guidelines on the management of IgE-mediated food allergies: S2k-Guidelines of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Medical Association of Allergologists (AeDA), the German Professional Association of Pediatricians (BVKJ), the German Allergy and Asthma Association (DAAB), German Dermatological Society (DDG), the German Society for Nutrition (DGE), the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS), the G." Allergo journal international vol. 24 (2015): 256-293. doi: https://doi.org/10.1007/s40629-015-0074-0
Worm M, Reese I, Ballmer-Weber B, Beyer K, Bischoff SC, Classen M, Fischer PJ, Fuchs T, Huttegger I, Jappe U, Klimek L, Koletzko B, Lange L, Lepp U, Mahler V, Niggemann B, Rabe U, Raithel M, Saloga J, Schäfer C, Schnadt S, Schreiber J, Szépfalusi Z, Treudler R, Wagenmann M, Watzl B, Werfel T, Zuberbier T, Kleine-Tebbe J. Guidelines on the management of IgE-mediated food allergies: S2k-Guidelines of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Medical Association of Allergologists (AeDA), the German Professional Association of Pediatricians (BVKJ), the German Allergy and Asthma Association (DAAB), German Dermatological Society (DDG), the German Society for Nutrition (DGE), the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS), the G. Allergo J Int. 2015;24:256-293. doi: 10.1007/s40629-015-0074-0. Epub 2015 Nov 07. PMID: 27069841; PMCID: PMC4792347.
Copy Download .nbib Format: NLM
Allergen immunotherapy for allergic asthma: protocol for a systematic review.

Clinical and translational allergy

Dhami S, Nurmatov U, Agache I, Lau S, Muraro A, Jutel M, Roberts G, Akdis C, Bonini M, Calderon M, Casale T, Cavkaytar O, Cox L, Demoly P, Flood B, Hamelmann E, Izuhara K, Kalayci Ö, Kleine-Tebbe J, Nieto A, Papadopoulos N, Pfaar O, Rosenwasser L, Ryan D, Schmidt-Weber C, Szefler S, Wahn U, van Wijk RG, Wilkinson J, Sheikh A.
PMID: 26862389
Clin Transl Allergy. 2016 Feb 09;6:5. doi: 10.1186/s13601-016-0094-y. eCollection 2015.

BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for Allergic Asthma. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in...

Cite
Dhami S, Nurmatov U, Agache I, et al. Allergen immunotherapy for allergic asthma: protocol for a systematic review. Clin Transl Allergy. 2016;6:5doi: 10.1186/s13601-016-0094-y.
Dhami, S., Nurmatov, U., Agache, I., Lau, S., Muraro, A., Jutel, M., Roberts, G., Akdis, C., Bonini, M., Calderon, M., Casale, T., Cavkaytar, O., Cox, L., Demoly, P., Flood, B., Hamelmann, E., Izuhara, K., Kalayci, �. �., Kleine-Tebbe, J., Nieto, A., Papadopoulos, N., Pfaar, O., Rosenwasser, L., Ryan, D., Schmidt-Weber, C., Szefler, S., Wahn, U., van Wijk, R. G., Wilkinson, J., & Sheikh, A. (2015). Allergen immunotherapy for allergic asthma: protocol for a systematic review. Clinical and translational allergy, 65. https://doi.org/10.1186/s13601-016-0094-y
Dhami, Sangeeta, et al. "Allergen immunotherapy for allergic asthma: protocol for a systematic review." Clinical and translational allergy vol. 6 (2015): 5. doi: https://doi.org/10.1186/s13601-016-0094-y
Dhami S, Nurmatov U, Agache I, Lau S, Muraro A, Jutel M, Roberts G, Akdis C, Bonini M, Calderon M, Casale T, Cavkaytar O, Cox L, Demoly P, Flood B, Hamelmann E, Izuhara K, Kalayci Ö, Kleine-Tebbe J, Nieto A, Papadopoulos N, Pfaar O, Rosenwasser L, Ryan D, Schmidt-Weber C, Szefler S, Wahn U, van Wijk RG, Wilkinson J, Sheikh A. Allergen immunotherapy for allergic asthma: protocol for a systematic review. Clin Transl Allergy. 2016 Feb 09;6:5. doi: 10.1186/s13601-016-0094-y. eCollection 2015. PMID: 26862389; PMCID: PMC4746770.
Copy Download .nbib Format: NLM
Benefits and limitations of molecular diagnostics in peanut allergy: Part 14 of the series Molecular Allergology.

Allergo journal international

Lange L, Beyer K, Kleine-Tebbe J.
PMID: 26120527
Allergo J Int. 2014;23(5):158-163. doi: 10.1007/s40629-014-0019-z. Epub 2014 Aug 07.

Allergic reactions to peanut (

Cite
Lange L, Beyer K, Kleine-Tebbe J. Benefits and limitations of molecular diagnostics in peanut allergy: Part 14 of the series Molecular Allergology. Allergo J Int. 2014;23(5):158-163doi: 10.1007/s40629-014-0019-z.
Lange, L., Beyer, K., & Kleine-Tebbe, J. (2014). Benefits and limitations of molecular diagnostics in peanut allergy: Part 14 of the series Molecular Allergology. Allergo journal international, 23(5), 158-163. https://doi.org/10.1007/s40629-014-0019-z
Lange, Lars, et al. "Benefits and limitations of molecular diagnostics in peanut allergy: Part 14 of the series Molecular Allergology." Allergo journal international vol. 23,5 (2014): 158-163. doi: https://doi.org/10.1007/s40629-014-0019-z
Lange L, Beyer K, Kleine-Tebbe J. Benefits and limitations of molecular diagnostics in peanut allergy: Part 14 of the series Molecular Allergology. Allergo J Int. 2014;23(5):158-163. doi: 10.1007/s40629-014-0019-z. Epub 2014 Aug 07. PMID: 26120527; PMCID: PMC4479434.
Copy Download .nbib Format: NLM
Molecular allergy diagnostic tests: development and relevance in clinical practice.

Allergologie select

Kleine-Tebbe J, Jappe U.
PMID: 30402615
Allergol Select. 2017 Aug 04;1(2):169-189. doi: 10.5414/ALX01617E. eCollection 2017.

Molecular allergy is based on identification, characterization and subsequent use of single allergens, being components of complex allergen sources like pollen, mites, furred animals, foods or insect venoms. Only few protein families contain relevant allergens of similar sequence and...

Cite
Kleine-Tebbe J, Jappe U. Molecular allergy diagnostic tests: development and relevance in clinical practice. Allergol Select. 2017;1(2):169-189doi: 10.5414/ALX01617E.
Kleine-Tebbe, J., & Jappe, U. (2017). Molecular allergy diagnostic tests: development and relevance in clinical practice. Allergologie select, 1(2), 169-189. https://doi.org/10.5414/ALX01617E
Kleine-Tebbe, J, and Jappe, U. "Molecular allergy diagnostic tests: development and relevance in clinical practice." Allergologie select vol. 1,2 (2017): 169-189. doi: https://doi.org/10.5414/ALX01617E
Kleine-Tebbe J, Jappe U. Molecular allergy diagnostic tests: development and relevance in clinical practice. Allergol Select. 2017 Aug 04;1(2):169-189. doi: 10.5414/ALX01617E. eCollection 2017. PMID: 30402615; PMCID: PMC6040004.
Copy Download .nbib Format: NLM
Non-celiac gluten/wheat sensitivity (NCGS)-a currently undefined disorder without validated diagnostic criteria and of unknown prevalence: Position statement of the task force on food allergy of the German Society of Allergology and Clinical Immunology (DGAKI).

Allergo journal international

Reese I, Schäfer C, Kleine-Tebbe J, Ahrens B, Bachmann O, Ballmer-Weber B, Beyer K, Bischoff SC, Blümchen K, Dölle S, Enck P, Enninger A, Huttegger I, Lämmel S, Lange L, Lepp U, Mahler V, Mönnikes H, Ockenga J, Otto B, Schnadt S, Szepfalusi Z, Treudler R, Wassmann-Otto A, Zuberbier T, Werfel T, Worm M.
PMID: 30294520
Allergo J Int. 2018;27(5):147-151. doi: 10.1007/s40629-018-0070-2. Epub 2018 May 28.

Within the last decade, non-celiac gluten/wheat sensitivity (NCGS) has been increasingly discussed not only in the media but also among medical specialties. The existence and the possible triggers of NCGS are controversial. Three international expert meetings which proposed recommendations...

Cite
Reese I, Schäfer C, Kleine-Tebbe J, et al. Non-celiac gluten/wheat sensitivity (NCGS)-a currently undefined disorder without validated diagnostic criteria and of unknown prevalence: Position statement of the task force on food allergy of the German Society of Allergology and Clinical Immunology (DGAKI). Allergo J Int. 2018;27(5):147-151doi: 10.1007/s40629-018-0070-2.
Reese, I., Schäfer, C., Kleine-Tebbe, J., Ahrens, B., Bachmann, O., Ballmer-Weber, B., Beyer, K., Bischoff, S. C., Blümchen, K., Dölle, S., Enck, P., Enninger, A., Huttegger, I., Lämmel, S., Lange, L., Lepp, U., Mahler, V., Mönnikes, H., Ockenga, J., Otto, B., Schnadt, S., Szepfalusi, Z., Treudler, R., Wassmann-Otto, A., Zuberbier, T., Werfel, T., & Worm, M. (2018). Non-celiac gluten/wheat sensitivity (NCGS)-a currently undefined disorder without validated diagnostic criteria and of unknown prevalence: Position statement of the task force on food allergy of the German Society of Allergology and Clinical Immunology (DGAKI). Allergo journal international, 27(5), 147-151. https://doi.org/10.1007/s40629-018-0070-2
Reese, Imke, et al. "Non-celiac gluten/wheat sensitivity (NCGS)-a currently undefined disorder without validated diagnostic criteria and of unknown prevalence: Position statement of the task force on food allergy of the German Society of Allergology and Clinical Immunology (DGAKI)." Allergo journal international vol. 27,5 (2018): 147-151. doi: https://doi.org/10.1007/s40629-018-0070-2
Reese I, Schäfer C, Kleine-Tebbe J, Ahrens B, Bachmann O, Ballmer-Weber B, Beyer K, Bischoff SC, Blümchen K, Dölle S, Enck P, Enninger A, Huttegger I, Lämmel S, Lange L, Lepp U, Mahler V, Mönnikes H, Ockenga J, Otto B, Schnadt S, Szepfalusi Z, Treudler R, Wassmann-Otto A, Zuberbier T, Werfel T, Worm M. Non-celiac gluten/wheat sensitivity (NCGS)-a currently undefined disorder without validated diagnostic criteria and of unknown prevalence: Position statement of the task force on food allergy of the German Society of Allergology and Clinical Immunology (DGAKI). Allergo J Int. 2018;27(5):147-151. doi: 10.1007/s40629-018-0070-2. Epub 2018 May 28. PMID: 30294520; PMCID: PMC6153714.
Copy Download .nbib Format: NLM
Severe allergic reactions to the COVID-19 vaccine - statement and practical consequences.

Allergologie select

Kleine-Tebbe J, Klimek L, Hamelmann E, Pfaar O, Taube C, Wagenmann M, Werfel T, Worm M.
PMID: 33426427
Allergol Select. 2021 Jan 05;5:26-28. doi: 10.5414/ALX02215E. eCollection 2021.

No abstract available.

Cite
Kleine-Tebbe J, Klimek L, Hamelmann E, et al. Severe allergic reactions to the COVID-19 vaccine - statement and practical consequences. Allergol Select. 2021;5:26-28doi: 10.5414/ALX02215E.
Kleine-Tebbe, J., Klimek, L., Hamelmann, E., Pfaar, O., Taube, C., Wagenmann, M., Werfel, T., & Worm, M. (2021). Severe allergic reactions to the COVID-19 vaccine - statement and practical consequences. Allergologie select, 526-28. https://doi.org/10.5414/ALX02215E
Kleine-Tebbe, Jörg, et al. "Severe allergic reactions to the COVID-19 vaccine - statement and practical consequences." Allergologie select vol. 5 (2021): 26-28. doi: https://doi.org/10.5414/ALX02215E
Kleine-Tebbe J, Klimek L, Hamelmann E, Pfaar O, Taube C, Wagenmann M, Werfel T, Worm M. Severe allergic reactions to the COVID-19 vaccine - statement and practical consequences. Allergol Select. 2021 Jan 05;5:26-28. doi: 10.5414/ALX02215E. eCollection 2021. PMID: 33426427; PMCID: PMC7787363.
Copy Download .nbib Format: NLM
Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA Group.

Allergologie select

Klimek L, Pfaar O, Worm M, Bergmann KC, Bieber T, Buhl R, Buters J, Darsow U, Keil T, Kleine-Tebbe J, Lau S, Maurer M, Merk H, Mösges R, Saloga J, Staubach P, Stute P, Rabe K, Rabe U, Vogelmeier C, Biedermann T, Jung K, Schlenter W, Ring J, Chaker A, Wehrmann W, Becker S, Mülleneisen N, Nemat K, Czech W, Wrede H, Brehler R, Fuchs T, Tomazic PV, Aberer W, Fink-Wagner A, Horak F, Wöhrl S, Niederberger-Leppin V, Pali-Schöll I, Pohl W, Roller-Wirnsberger R, Spranger O, Valenta R, Akdis M, Akdis C, Hoffmann-Sommergruber K, Jutel M, Matricardi P, Spertin F, Khaltaev N, Michel JP, Nicod L, Schmid-Grendelmeier P, Hamelmann E, Jakob T, Werfel T, Wagenmann M, Taube C, Gerstlauer M, Vogelberg C, Bousquet J, Zuberbier T.
PMID: 32568272
Allergol Select. 2020 May 28;4:44-52. doi: 10.5414/ALX02147E. eCollection 2020.

No abstract available.

Cite
Klimek L, Pfaar O, Worm M, et al. Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA Group. Allergol Select. 2020;4:44-52doi: 10.5414/ALX02147E.
Klimek, L., Pfaar, O., Worm, M., Bergmann, K. C., Bieber, T., Buhl, R., Buters, J., Darsow, U., Keil, T., Kleine-Tebbe, J., Lau, S., Maurer, M., Merk, H., Mösges, R., Saloga, J., Staubach, P., Stute, P., Rabe, K., Rabe, U., Vogelmeier, C., Biedermann, T., Jung, K., Schlenter, W., Ring, J., Chaker, A., Wehrmann, W., Becker, S., Mülleneisen, N., Nemat, K., Czech, W., Wrede, H., Brehler, R., Fuchs, T., Tomazic, P. V., Aberer, W., Fink-Wagner, A., Horak, F., Wöhrl, S., Niederberger-Leppin, V., Pali-Schöll, I., Pohl, W., Roller-Wirnsberger, R., Spranger, O., Valenta, R., Akdis, M., Akdis, C., Hoffmann-Sommergruber, K., Jutel, M., Matricardi, P., Spertin, F., Khaltaev, N., Michel, J. P., Nicod, L., Schmid-Grendelmeier, P., Hamelmann, E., Jakob, T., Werfel, T., Wagenmann, M., Taube, C., Gerstlauer, M., Vogelberg, C., Bousquet, J., & Zuberbier, T. (2020). Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA Group. Allergologie select, 444-52. https://doi.org/10.5414/ALX02147E
Klimek, Ludger, et al. "Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA Group." Allergologie select vol. 4 (2020): 44-52. doi: https://doi.org/10.5414/ALX02147E
Klimek L, Pfaar O, Worm M, Bergmann KC, Bieber T, Buhl R, Buters J, Darsow U, Keil T, Kleine-Tebbe J, Lau S, Maurer M, Merk H, Mösges R, Saloga J, Staubach P, Stute P, Rabe K, Rabe U, Vogelmeier C, Biedermann T, Jung K, Schlenter W, Ring J, Chaker A, Wehrmann W, Becker S, Mülleneisen N, Nemat K, Czech W, Wrede H, Brehler R, Fuchs T, Tomazic PV, Aberer W, Fink-Wagner A, Horak F, Wöhrl S, Niederberger-Leppin V, Pali-Schöll I, Pohl W, Roller-Wirnsberger R, Spranger O, Valenta R, Akdis M, Akdis C, Hoffmann-Sommergruber K, Jutel M, Matricardi P, Spertin F, Khaltaev N, Michel JP, Nicod L, Schmid-Grendelmeier P, Hamelmann E, Jakob T, Werfel T, Wagenmann M, Taube C, Gerstlauer M, Vogelberg C, Bousquet J, Zuberbier T. Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA Group. Allergol Select. 2020 May 28;4:44-52. doi: 10.5414/ALX02147E. eCollection 2020. PMID: 32568272; PMCID: PMC7304289.
Copy Download .nbib Format: NLM
Molecular allergology and its impact in specific allergy diagnosis and therapy.

Allergy

Barber D, Diaz-Perales A, Escribese MM, Kleine-Tebbe J, Matricardi PM, Ollert M, Santos AF, Sastre J.
PMID: 34057744
Allergy. 2021 Dec;76(12):3642-3658. doi: 10.1111/all.14969. Epub 2021 Jun 22.

Progressive knowledge of allergenic structures resulted in a broad availability of allergenic molecules for diagnosis. Component-resolved diagnosis allowed a better understanding of patient sensitization patterns, facilitating allergen immunotherapy decisions. In parallel to the discovery of allergenic molecules, there was...

Cite
Barber D, Diaz-Perales A, Escribese MM, et al. Molecular allergology and its impact in specific allergy diagnosis and therapy. Allergy. 2021;76(12):3642-3658doi: 10.1111/all.14969.
Barber, D., Diaz-Perales, A., Escribese, M. M., Kleine-Tebbe, J., Matricardi, P. M., Ollert, M., Santos, A. F., & Sastre, J. (2021). Molecular allergology and its impact in specific allergy diagnosis and therapy. Allergy, 76(12), 3642-3658. https://doi.org/10.1111/all.14969
Barber, Domingo, et al. "Molecular allergology and its impact in specific allergy diagnosis and therapy." Allergy vol. 76,12 (2021): 3642-3658. doi: https://doi.org/10.1111/all.14969
Barber D, Diaz-Perales A, Escribese MM, Kleine-Tebbe J, Matricardi PM, Ollert M, Santos AF, Sastre J. Molecular allergology and its impact in specific allergy diagnosis and therapy. Allergy. 2021 Dec;76(12):3642-3658. doi: 10.1111/all.14969. Epub 2021 Jun 22. PMID: 34057744.
Copy Download .nbib Format: NLM
New trends in anaphylaxis.

Allergo journal international

Worm M, Sturm G, Kleine-Tebbe J, Cichocka-Jarosz E, Cardona V, Maris I, Dölle S.
PMID: 29214141
Allergo J Int. 2017;26(8):295-300. doi: 10.1007/s40629-017-0042-y. Epub 2017 Nov 15.

This review presents the current trends in anaphylaxis management discussed at the fourth International Network for Online-Registration of Anaphylaxis (NORA) conference held in Berlin in April 2017. Current data from the anaphylaxis registry show that Hymenoptera venom, foods, and...

Cite
Worm M, Sturm G, Kleine-Tebbe J, et al. New trends in anaphylaxis. Allergo J Int. 2017;26(8):295-300doi: 10.1007/s40629-017-0042-y.
Worm, M., Sturm, G., Kleine-Tebbe, J., Cichocka-Jarosz, E., Cardona, V., Maris, I., & Dölle, S. (2017). New trends in anaphylaxis. Allergo journal international, 26(8), 295-300. https://doi.org/10.1007/s40629-017-0042-y
Worm, Margitta, et al. "New trends in anaphylaxis." Allergo journal international vol. 26,8 (2017): 295-300. doi: https://doi.org/10.1007/s40629-017-0042-y
Worm M, Sturm G, Kleine-Tebbe J, Cichocka-Jarosz E, Cardona V, Maris I, Dölle S. New trends in anaphylaxis. Allergo J Int. 2017;26(8):295-300. doi: 10.1007/s40629-017-0042-y. Epub 2017 Nov 15. PMID: 29214141; PMCID: PMC5705757.
Copy Download .nbib Format: NLM
Molecular allergy diagnostics using IgE singleplex determinations: methodological and practical considerations for use in clinical routine: Part 18 of the Series Molecular Allergology.

Allergo journal international

Kleine-Tebbe J, Jakob T.
PMID: 27069839
Allergo J Int. 2015;24:185-197. doi: 10.1007/s40629-015-0067-z. Epub 2015 Sep 28.

Allergen molecules (synonyms: single allergens, allergen components) open up new horizons for the targeted allergen-specific diagnostics of immunoglobulin E (IgE) in singleplex determination. The following rationales support the targeted use of allergen molecules and, more importantly, improve test properties:...

Cite
Kleine-Tebbe J, Jakob T. Molecular allergy diagnostics using IgE singleplex determinations: methodological and practical considerations for use in clinical routine: Part 18 of the Series Molecular Allergology. Allergo J Int. 2015;24:185-197doi: 10.1007/s40629-015-0067-z.
Kleine-Tebbe, J., & Jakob, T. (2015). Molecular allergy diagnostics using IgE singleplex determinations: methodological and practical considerations for use in clinical routine: Part 18 of the Series Molecular Allergology. Allergo journal international, 24185-197. https://doi.org/10.1007/s40629-015-0067-z
Kleine-Tebbe, Jörg, and Jakob, Thilo. "Molecular allergy diagnostics using IgE singleplex determinations: methodological and practical considerations for use in clinical routine: Part 18 of the Series Molecular Allergology." Allergo journal international vol. 24 (2015): 185-197. doi: https://doi.org/10.1007/s40629-015-0067-z
Kleine-Tebbe J, Jakob T. Molecular allergy diagnostics using IgE singleplex determinations: methodological and practical considerations for use in clinical routine: Part 18 of the Series Molecular Allergology. Allergo J Int. 2015;24:185-197. doi: 10.1007/s40629-015-0067-z. Epub 2015 Sep 28. PMID: 27069839; PMCID: PMC4792337.
Copy Download .nbib Format: NLM
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients.

Clinical and translational allergy

Rieker-Schwienbacher J, Nell MJ, Diamant Z, van Ree R, Distler A, Boot JD, Kleine-Tebbe J.
PMID: 23657148
Clin Transl Allergy. 2013 May 08;3(1):16. doi: 10.1186/2045-7022-3-16.

BACKGROUND: The current maintenance dose (10,000 AUeq/monthly) of a subcutaneous allergoid for house dust mite (HDM) immunotherapy has previously shown significant clinical efficacy in patients with HDM induced allergic rhinitis or rhinoconjunctivitis. In order to comply with the 2009...

Cite
Rieker-Schwienbacher J, Nell MJ, Diamant Z, et al. Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients. Clin Transl Allergy. 2013;3(1):16doi: 10.1186/2045-7022-3-16.
Rieker-Schwienbacher, J., Nell, M. J., Diamant, Z., van Ree, R., Distler, A., Boot, J. D., & Kleine-Tebbe, J. (2013). Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients. Clinical and translational allergy, 3(1), 16. https://doi.org/10.1186/2045-7022-3-16
Rieker-Schwienbacher, Juliane, et al. "Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients." Clinical and translational allergy vol. 3,1 (2013): 16. doi: https://doi.org/10.1186/2045-7022-3-16
Rieker-Schwienbacher J, Nell MJ, Diamant Z, van Ree R, Distler A, Boot JD, Kleine-Tebbe J. Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients. Clin Transl Allergy. 2013 May 08;3(1):16. doi: 10.1186/2045-7022-3-16. PMID: 23657148; PMCID: PMC3658910.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 43 entries